These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39056399)

  • 21. Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy.
    Oba MC; Askin O; Balci Ekmekci O; Serdaroglu S
    J Cosmet Dermatol; 2021 Mar; 20(3):971-975. PubMed ID: 32808476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature.
    Chiang A; Ortenzio F; Juhasz MLW; Yu V; Mesinkovska NA
    JAAD Case Rep; 2018 Aug; 4(7):733-736. PubMed ID: 30167448
    [No Abstract]   [Full Text] [Related]  

  • 23. Excellent response to tofacitinib treatment in a patient with alopecia universalis.
    Erduran F; Adışen E; Aksakal AB
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):47-49. PubMed ID: 28632888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.
    Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J
    J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis.
    Abe DT; Tashima LM; Basilio FMA; Mulinari-Brenner F
    Int J Trichology; 2020; 12(4):188-190. PubMed ID: 33376289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System.
    Song CJ; Riley CA; Wilkison BD; Cho S
    Mil Med; 2024 Jun; ():. PubMed ID: 38850223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral tofacitinib for the treatment of alopecia areata in pediatric patients.
    Kibbie J; Kines K; Norris D; Dunnick CA
    Pediatr Dermatol; 2022 Jan; 39(1):31-34. PubMed ID: 34779041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata.
    Deeb M; Beach RA
    J Cutan Med Surg; 2017; 21(6):562-563. PubMed ID: 28635319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.
    Taylor S; Korman NJ; Tsai TF; Shimomura Y; Feely M; Dutronc Y; Wu WS; Somani N; Tosti A
    Dermatol Ther (Heidelb); 2023 Dec; 13(12):3181-3191. PubMed ID: 37740856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway.
    Sardana K; Bathula S; Khurana A
    Indian Dermatol Online J; 2023; 14(4):465-474. PubMed ID: 37521227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis.
    Esteves M; Lopes S; Azevedo F; Pedrosa A
    Skin Appendage Disord; 2021 Jan; 7(1):36-40. PubMed ID: 33614717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata.
    Chikhalkar SB; Prasanna S; Vishwanath T
    Indian Dermatol Online J; 2024; 15(4):624-629. PubMed ID: 39050046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
    Mikhaylov D; Glickman JW; Del Duca E; Nia J; Hashim P; Singer GK; Posligua AL; Florek AG; Ibler E; Hagstrom EL; Estrada Y; Rangel SM; Colavincenzo M; Paller AS; Guttman-Yassky E
    Arch Dermatol Res; 2023 Mar; 315(2):181-189. PubMed ID: 35230488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Janus kinase inhibitors for alopecia areata: A narrative review.
    Haughton RD; Herbert SM; Ji-Xu A; Downing L; Raychaudhuri SP; Maverakis E
    Indian J Dermatol Venereol Leprol; 2023; 89(6):799-806. PubMed ID: 37436019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience.
    Van ATT; Lan AT; Anh MH; Van TN; Minh PPT; Thi PT; Minh TT; Huu ND; Thanh TV; Huyen ML; Hau KT; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
    Open Access Maced J Med Sci; 2019 Jan; 7(2):200-203. PubMed ID: 30745958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mini pulse corticosteroid therapy with oral dexamethasone for moderate to severe alopecia areata: A multicentric study.
    Lobato-Berezo A; March-Rodríguez A; Grimalt R; Rodríguez-Lomba E; Setó-Torrent N; Pujol RM; Ruiz-Villaverde R
    Dermatol Ther; 2022 Nov; 35(11):e15806. PubMed ID: 36070222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical Trial.
    Joly P; Lafon A; Houivet E; Donnadieu N; Richard MA; Dupuy A; Delaporte E; Bernard P; Machet L; Tosti A; Del Marmol V; Grimalt R; de Viragh PA; Benichou J; Chosidow O; Assouly P; Reygagne P
    JAMA Dermatol; 2023 Apr; 159(4):403-410. PubMed ID: 36884234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.
    Yu DA; Kim YE; Kwon O; Park H
    Indian J Dermatol Venereol Leprol; 2021; 87(5):621-627. PubMed ID: 34379968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis.
    Wei D; Chen Y; Shen Y; Xie B; Song X
    Front Immunol; 2023; 14():1152513. PubMed ID: 37138884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tofacitinib for the treatment of alopecia areata and variants in adolescents.
    Craiglow BG; Liu LY; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):29-32. PubMed ID: 27816292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.